These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 31595083)

  • 1. CGRP-targeted antibodies in difficult-to-treat migraine.
    de Vries T; MaassenVanDenBrink A
    Nat Rev Neurol; 2019 Dec; 15(12):688-689. PubMed ID: 31595083
    [No Abstract]   [Full Text] [Related]  

  • 2. Calcitonin Gene-Related Protein (CGRP)-Targeted Treatments for Migraine Prevention.
    Tepper DE
    Headache; 2019 Mar; 59(3):477-480. PubMed ID: 30825209
    [No Abstract]   [Full Text] [Related]  

  • 3. Calcitonin Gene-Related Peptide-Targeted Therapies for Migraine and Cluster Headache: A Review.
    Schuster NM; Rapoport AM
    Clin Neuropharmacol; 2017; 40(4):169-174. PubMed ID: 28644160
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CGRP, a target for preventive therapy in migraine and cluster headache: Systematic review of clinical data.
    Khan S; Olesen A; Ashina M
    Cephalalgia; 2019 Mar; 39(3):374-389. PubMed ID: 29110503
    [TBL] [Abstract][Full Text] [Related]  

  • 5. History and Review of anti-Calcitonin Gene-Related Peptide (CGRP) Therapies: From Translational Research to Treatment.
    Tepper SJ
    Headache; 2018 Nov; 58 Suppl 3():238-275. PubMed ID: 30242830
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Calcitonin gene-related peptide (CGRP) and migraine current understanding and state of development.
    Bigal ME; Walter S; Rapoport AM
    Headache; 2013 Sep; 53(8):1230-44. PubMed ID: 23848260
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Calcitonin gene-related peptide - beyond migraine prophylaxis.
    Olesen J; Ashina M
    Nat Rev Neurol; 2019 Oct; 15(10):562-564. PubMed ID: 31488896
    [No Abstract]   [Full Text] [Related]  

  • 8. How to integrate monoclonal antibodies targeting the calcitonin gene-related peptide or its receptor in daily clinical practice.
    Tiseo C; Ornello R; Pistoia F; Sacco S
    J Headache Pain; 2019 May; 20(1):49. PubMed ID: 31060490
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The CGRP Pathway in Migraine as a Viable Target for Therapies.
    Edvinsson L
    Headache; 2018 May; 58 Suppl 1():33-47. PubMed ID: 29697153
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Therapeutic antibodies against CGRP or its receptor.
    Bigal ME; Walter S; Rapoport AM
    Br J Clin Pharmacol; 2015 Jun; 79(6):886-95. PubMed ID: 25614243
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Patent watch: Migraine therapies targeting the CGRP pathway: intellectual property landscape.
    Fiala JL; Lowery D
    Nat Rev Drug Discov; 2016 Jan; 15(1):8-9. PubMed ID: 26669672
    [No Abstract]   [Full Text] [Related]  

  • 12. Getting closer to a cure for migraine.
    Tassorelli C; De Icco R
    Nat Rev Neurol; 2019 Feb; 15(2):64-65. PubMed ID: 30655610
    [No Abstract]   [Full Text] [Related]  

  • 13. Problematic presentation and use of efficacy measures in current trials of CGRP monoclonal antibodies for episodic migraine prevention: A mini-review.
    Tfelt-Hansen P; Diener HC; Steiner TJ
    Cephalalgia; 2020 Jan; 40(1):122-126. PubMed ID: 31547694
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Foreword: The CGRP Pathway and Migraine Prevention: Reducing the Burden of Disease.
    Holland PR
    Headache; 2018 May; 58 Suppl 1():1-3. PubMed ID: 29697155
    [No Abstract]   [Full Text] [Related]  

  • 15. CGRP and Migraine: The Role of Blocking Calcitonin Gene-Related Peptide Ligand and Receptor in the Management of Migraine.
    Maasumi K; Michael RL; Rapoport AM
    Drugs; 2018 Jun; 78(9):913-928. PubMed ID: 29869205
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of Anti-Calcitonin Gene-Related Peptide for Migraines: A Systematic Review with Meta-Analysis of Randomized Clinical Trials.
    Huang IH; Wu PC; Lin EY; Chen CY; Kang YN
    Int J Mol Sci; 2019 Jul; 20(14):. PubMed ID: 31323828
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CGRP ligand and receptor monoclonal antibodies for migraine prevention: Evidence review and clinical implications.
    Dodick DW
    Cephalalgia; 2019 Mar; 39(3):445-458. PubMed ID: 30661365
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Botulinum Toxin in the Treatment of Headache.
    Becker WJ
    Toxins (Basel); 2020 Dec; 12(12):. PubMed ID: 33348571
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CGRP - a target for acute therapy in migraine: Clinical data.
    Messina R; Goadsby PJ
    Cephalalgia; 2019 Mar; 39(3):420-427. PubMed ID: 29616830
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Targeting calcitonin gene-related peptide: a new era in migraine therapy.
    Charles A; Pozo-Rosich P
    Lancet; 2019 Nov; 394(10210):1765-1774. PubMed ID: 31668411
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.